Navigation Links
Berkery Noyes Releases Third Quarter 2011 Mergers & Acquisitions Update for the Pharma and Healthcare Information and Technology Industry
Date:10/17/2011

NEW YORK, Oct. 17, 2011 /PRNewswire/ -- Berkery Noyes, the leading independent investment bank specializing in the information content and technology industries, today released its Third Quarter 2011 Mergers and Acquisitions Update for the Pharma and Healthcare Information and Technology Industry.

The report analyzes merger and acquisition activity over the first three quarters of 2011 and compares it with activity in 2010. This market includes information and technology companies servicing pharma, healthcare payer and healthcare provider spaces.

According to Berkery Noyes research, the report showed third quarter transaction volume decreased 6 percent over the previous period. However, transaction value increased 245 percent in the third quarter. This sharp increase can be explained by Blackstone Group's announced third quarter acquisition of Emdeon for $3.03 billion, the largest transaction thus far in 2011.

Median EBITDA multiples from 2010 to the first nine months of 2011 went from 11.8 to 10.8, an 8 percent decrease, while median revenue multiples decreased from 2.0 to 1.8, a 10 percent decline.

The most active acquirer through the third quarter was PerkinElmer with four acquisitions: Labtronics, Geospiza, CambridgeSoft, and ArtusLabs.

"PerkinElmer has demonstrated the vast potential for informatics and software integration into laboratory environments," said managing director Jeffrey Smith. "The need to integrate scientific tools, effectively manage knowledge, and organize workflow within laboratory settings is becoming even more crucial for clients of organizations such as PerkinElmer."

Berkery Noyes specializes in Mergers & Acquisitions advisory services, in addition to structuring debt and equity transactions in the $25 million to $500 million range. Unique among investment banking firms, Berkery Noyes combines independent strategic research and industry intelligence with senior information technology banking expertise. Long having been an innovator in database and research technology in M&A, Berkery Noyes has committed itself to providing more expansive and more current information. The firm's research teams publish acquisition activity in the respective sectors they follow on MandAsoft.com.

A copy of the THIRD QUARTER 2011 PHARMA AND HEALTHCARE INFORMATION AND TECHNOLOGY INDUSTRY MERGERS & ACQUISITIONS UPDATE is available at the Berkery Noyes website.

About Berkery Noyes

Berkery Noyes is an independent investment banking advisory firm servicing the information industry. Focused on middle-market corporations and financial sponsors, Berkery Noyes is committed to delivering a comprehensive array of industry-leading advisory services. Since its founding by Joseph W. Berkery in 1983, the firm has worked with corporate clients to grow through acquisition, divest non-core assets, and maximize shareholder returns through strategic transactions and restructurings. For private owners, Berkery Noyes helps create liquidity and execute timely exit strategies that achieve the personal and professional objectives. For more information, visit www.berkerynoyes.com.

Contact Information:
Katie Weathers
www.csg-pr.com
404-791-8245
kweathers@csg-pr.com


'/>"/>
SOURCE Berkery Noyes
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Berkery Noyes Releases First Half 2011 M&A Report for the Pharma and Healthcare Information and Technology Industry
2. Berkery Noyes Releases 2009 Pharma and Healthcare Information Merger & Acquisition Trends
3. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
4. OncoSec Releases Devices for Use in Clinical Trials
5. TheraVasc Releases Phase I Trial Data Demonstrating Safety of Drug in Diabetic Patients
6. Molecular Devices Releases Breakthrough TUNE Technology, Now Part of the SpectraMax® Paradigm® Multi-Mode Microplate Detection Platform
7. Medicomp Releases ICD-10-CM with New Version of the Powerful MEDCIN Engine®
8. Techne Corporation Releases Unaudited Fourth Quarter and Fiscal Year 2011 Results
9. R A E N Optics Launches New Website and Releases New Styles
10. Epitomics Releases New Antibodies Developed With the National Cancer Institutes Center for Cancer Research
11. Latest Releases of Elektas XiO Planning and Focal Contouring Systems Designed to Increase Efficiency in Planning Therapy for Patients with Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion to ... awards. Ranked as number one in the South Florida Business ... in Inc. 5000 yearly list, the national specialty pharmacy has ... Armando Bardisa will soon be honored by SFBJ as ... Set to receive his award in October, ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)... DIEGO , Sept. 22, 2017 AVACEN ... medical device is now successfully helping those with the ... Fibromyalgia diagnosed Amanda in Essex, ... dressed and washing my hair, experiencing no sleep at ... in painful spasm… I cannot recommend [the AVACEN 100] ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
Breaking Medicine News(10 mins):